Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity

Miki Ando(Houston Methodist), Valentina Hoyos(Houston Methodist), Shigeki Yagyu(Houston Methodist), W Tao(Houston Methodist), Carlos A. Ramos(Houston Methodist), Gianpietro Dotti(Houston Methodist), Malcolm K. Brenner(Houston Methodist), Lisa Bouchier‐Hayes(Houston Methodist)
Cancer Gene Therapy
October 17, 2014
10.1038/cgt.2014.53
Cited by 42Open Access
Full Text

Abstract

Related Papers

Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Jie Yang, Xuesong Liu, Kapil N. Bhalla et al.|Science|1997|4.9k
X-linked IAP is a direct inhibitor of cell-death proteases
Quinn L. Deveraux, Ryōsuke Takahashi, Guy S. Salvesen et al.|Nature|1997|1.9k
Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect
Uwe Fischer, Matthew T. Harting, Fernando Jiménez et al.|Stem Cells and Development|2008|1.3k
Induction of Apoptosis by Cancer Chemotherapy
Scott H. Kaufmann, William C. Earnshaw|Experimental Cell Research|2000|1.3k
The apoptosome: signalling platform of cell death
Stefan J. Riedl, Guy S. Salvesen|Nature Reviews Molecular Cell Biology|2007|1.1k